The first children have been vaccinated in Moderna’s Phase 2/3 pediatric Covid-1…
The first children have been vaccinated in Moderna’s Phase 2/3 pediatric Covid-19 vaccine trial, the company announced Tuesday. The clinical trial, called the KidCOVE study, will enroll approximately 6,750 children in the US and Canada between the ages of 6 months and 11 years old. Moderna is doing the tests to see if the vaccine protects children from getting sick if they come into contact with coronavirus, according to the clinical trial’s patient information website. The Pfizer/BioNTech Covid-19 vaccine is being studied in children as well, and Johnson & Johnson has announced plans to study the vaccine in adolescents, ages 12 to 18.
(📸: Frederic J. Brown/AFP/Getty Images)
Credit to the Original Source